These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 29321180)

  • 1. Two-year neurodevelopmental outcomes of extremely preterm infants treated with early hydrocortisone: treatment effect according to gestational age at birth.
    Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
    Arch Dis Child Fetal Neonatal Ed; 2019 Jan; 104(1):F30-F35. PubMed ID: 29321180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Early Low-Dose Hydrocortisone Therapy in Extremely Preterm Neonates and Neurodevelopmental Outcomes at 2 Years of Age.
    Baud O; Trousson C; Biran V; Leroy E; Mohamed D; Alberti C;
    JAMA; 2017 Apr; 317(13):1329-1337. PubMed ID: 28384828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodevelopmental outcome in extremely preterm infants at 2.5 years after active perinatal care in Sweden.
    Serenius F; Källén K; Blennow M; Ewald U; Fellman V; Holmström G; Lindberg E; Lundqvist P; Maršál K; Norman M; Olhager E; Stigson L; Stjernqvist K; Vollmer B; Strömberg B;
    JAMA; 2013 May; 309(17):1810-20. PubMed ID: 23632725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants.
    Watterberg KL; Shaffer ML; Mishefske MJ; Leach CL; Mammel MC; Couser RJ; Abbasi S; Cole CH; Aucott SW; Thilo EH; Rozycki HJ; Lacy CB
    Pediatrics; 2007 Jul; 120(1):40-8. PubMed ID: 17606560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
    JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial.
    Baud O; Maury L; Lebail F; Ramful D; El Moussawi F; Nicaise C; Zupan-Simunek V; Coursol A; Beuchée A; Bolot P; Andrini P; Mohamed D; Alberti C;
    Lancet; 2016 Apr; 387(10030):1827-36. PubMed ID: 26916176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental Outcomes of Infants Born at <29 Weeks of Gestation Admitted to Canadian Neonatal Intensive Care Units Based on Location of Birth.
    Amer R; Moddemann D; Seshia M; Alvaro R; Synnes A; Lee KS; Lee SK; Shah PS;
    J Pediatr; 2018 May; 196():31-37.e1. PubMed ID: 29305231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity of perinatal care for extremely preterm infants: outcomes at 2.5 years.
    Serenius F; Blennow M; Maršál K; Sjörs G; Källen K;
    Pediatrics; 2015 May; 135(5):e1163-72. PubMed ID: 25896833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early low-dose hydrocortisone: is the neurodevelopment affected?
    Ofman G; Perez M; Farrow KN
    J Perinatol; 2018 Jun; 38(6):636-638. PubMed ID: 29467523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-life respiratory trajectories and neurodevelopmental outcomes in infants born very and extremely preterm: A retrospective study.
    Yu WH; Chu CH; Lin YC; Chen RB; Iwata O; Huang CC
    Dev Med Child Neurol; 2022 Oct; 64(10):1246-1253. PubMed ID: 35383902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of infants born at 22 and 23 weeks' gestation.
    Ishii N; Kono Y; Yonemoto N; Kusuda S; Fujimura M;
    Pediatrics; 2013 Jul; 132(1):62-71. PubMed ID: 23733804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year neurodevelopmental outcome in children born extremely preterm: the EPI-DAF study.
    van Beek PE; Rijken M; Broeders L; Ter Horst HJ; Koopman-Esseboom C; de Kort E; Laarman C; Mulder-de Tollenaer SM; Steiner K; Swarte RM; van Westering-Kroon E; Oei SG; Leemhuis AG; Andriessen P;
    Arch Dis Child Fetal Neonatal Ed; 2022 Sep; 107(5):467-474. PubMed ID: 35236745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental outcome at 2 years for preterm children born at 22 to 34 weeks' gestation in France in 2011: EPIPAGE-2 cohort study.
    Pierrat V; Marchand-Martin L; Arnaud C; Kaminski M; Resche-Rigon M; Lebeaux C; Bodeau-Livinec F; Morgan AS; Goffinet F; Marret S; Ancel PY;
    BMJ; 2017 Aug; 358():j3448. PubMed ID: 28814566
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
    Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
    Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodevelopmental outcome at 5.5 years in Dutch preterm infants born at 24-26 weeks' gestational age: the EPI-DAF study.
    van Beek PE; Rijken M; Broeders L; Ter Horst HJ; Koopman-Esseboom C; de Kort E; Laarman ARC; Mulder-de Tollenaer SM; Steiner K; Swarte RMC; van Westering-Kroon E; Oei G; Leemhuis AG; Andriessen P
    Arch Dis Child Fetal Neonatal Ed; 2024 Apr; 109(3):272-278. PubMed ID: 38071564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Extremely Preterm Infants With Birth Weight Less Than 400 g.
    Brumbaugh JE; Hansen NI; Bell EF; Sridhar A; Carlo WA; Hintz SR; Vohr BR; Colaizy TT; Duncan AF; Wyckoff MH; Baack ML; Rysavy MA; DeMauro SB; Stoll BJ; Das A; Higgins RD;
    JAMA Pediatr; 2019 May; 173(5):434-445. PubMed ID: 30907941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopmental impairment at 2 years of age in children born before 29 weeks' gestation with bronchopulmonary dysplasia.
    Decollogne L; Epiard C; Chevallier M; Ego A; Alin L; Debillon T
    Arch Pediatr; 2021 Jan; 28(1):23-28. PubMed ID: 33257210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental outcome after extreme prematurity: a review of the literature.
    Jarjour IT
    Pediatr Neurol; 2015 Feb; 52(2):143-52. PubMed ID: 25497122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental outcomes of premature infants with severe intraventricular hemorrhage.
    Calisici E; Eras Z; Oncel MY; Oguz SS; Gokce İK; Dilmen U
    J Matern Fetal Neonatal Med; 2015; 28(17):2115-20. PubMed ID: 25354288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.